PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) J Code: J9259

Drug & Product Overview

HCPCS Descriptor Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mg

HCPCS Added Date July 1, 2023

Manufacturer American Regent

Route of Administration Intravenous

Generic Status HCPCS Discontinued

Dosage Type Single-Dose

Dosage Form Injection, Powder, Lyophilized, For Suspension

About PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)

Paclitaxel Protein-bound (american Regent) is a medication aligned to the HCPCS J Code: J9259 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by American Regent.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to J9259. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Paclitaxel Protein-bound (american Regent) (J9259) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Adenocarcinoma of the Pancreas Metastatic Breast Cancer Non-Small Cell Lung Cancer

Drug Class

Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]

Frequently Asked Questions

Is there an available Paclitaxel Protein-Bound (American Regent) billing and coding guide?

Our team has identified a Paclitaxel Protein-Bound (American Regent) billing and coding guide published by the drug manufacturer: American Regent, Inc.. The guide can be found at the link below. Visit Here →

Are there any available Paclitaxel Protein-Bound (American Regent) patient assistance programs?

Our team did not identify a source for Paclitaxel Protein-Bound (American Regent) patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Paclitaxel Protein-Bound (American Regent) prescribing information?

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) prescribing information can be found at the link below: Visit Here →

Where can I find Paclitaxel Protein-Bound (American Regent) side effect information?

Our team has not yet identified a source of side effects information for PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT). Please check back in a few weeks.

Does billing PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) require JZ/JW wastage modifiers?

CMS has identified PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)(J9259) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.